carfilzomib
Carfilzomib is derived from epoxomicin, a natural product that was shown by the laboratory of Craig Crews at Yale University to inhibit the proteasome. It is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.. Reference standards of Carfilzomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => [(1S)-3-Methyl-1-[[(2S)-2-methyloxiranyl]carbonyl]butyl]-carbamic Acid 1,1-Dimethylethyl Ester
[catalogue_number] => PA 30 63600
[category_ids] => ,79,84,
[chemical_name] =>
[weight] => 271.35
[form] => C14H25NO4
[cas] => 247068-83-3
[pslug] => 247068-83-3-1s-3-methyl-1-2s-2-methyloxiranyl-carbonyl-butyl-carbamic-acid-1-1-dimethylethyl-ester-pa3063600
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
[(1S)-3-Methyl-1-[[(2S)-2-methyloxiranyl]carbonyl]butyl]-carbamic Acid 1,1-Dimethylethyl Ester
Catalogue No.:PA 30 63600
Molecular Formula : C14H25NO4
Molecular Weight : 271.35
